1 Ultra-Rush Specific Immune Therapy with Depigmented and Polymerized Allergen Extracts is Effective and Safe in Patients With Severe SAR Highly Sensitized against Pollen Allergens
2 Dose Optimizing Study of a Depigmented Polymerized Allergen Extract of Birch Pollen by Means of Conjunctival Provocation Test
3 Double-blind Study of the Use of Transfer Factor (TF) Combined With Sublingual Immunotherapy in Management of Patients With Allergic Rhinitis in Mexican Population
197 The Effectiveness of two Different Methods of Salbutamol Nebulization in Children with Asthma
4 The Risk of Severe Treatment Related Adverse Events is Significantly Lower in Children Compared to Adults When Treated With Standardized Timothy Grass Allergy Immunotherapy Tablets
5 Posttreatment, Long-Term Clinical Efficacy of a 300 IR Sublingual Tablet of 5-Grass Pollen Allergen Extract in Adults With Grass Pollen Induced Allergic Rhinoconjunctivitis
6 Escherichia coli Heat-Labile Enterotoxin (LTS61K) Modulates Dendritic Cell Function and Attenuates Airway Inflammation in Mouse Model of Allergic Asthma
7 Comparison of Efficacy and Safety of a Dipigmented Polymerized Allergen Extract of Grass and Birch with Placebo in Patients With Type-1 Allergic Rhinoconjunctivitis
8 Allergenic Composition of Polymerized Allergen Extracts of Betula verrucosa, Dermatophagoides Pteronyssinus and Phleum Pratense
9 A Proteomic Style Approach to Characterize a Grass Mix Product Reveals Potential Immunotherapeutic Benefit
10 Seasonal Versus Symptom-based Evaluation of a Depigmented Grass-Birch Allergoid
11 Efficacy and Tolerability of HDM Injective Immunotherapy With Monomeric Allergoid
12 Comprehensive Detection of Allergens in Grass Pollen Extracts by Mass Spectrometry
13 Gene Expression Pattern of Arabidopsis EXPB1, a Nonallergenic Homologue of Grass Group 1 Pollen Allergens
14 Comprehensive Expression of Recombinant House Dust Mite Allergens for Component-Resolved Diagnosis
15 A Bioinformatic Approach to Allergen Nomenclature Applied to Allergens From the Non-Biting Midge Chironomus thummi thummi
16 Pollen Allergens Differ From Nonallergenic Pollen Proteins by Their Lower Extent of Evolutionary Conservation
17 Sensitization to Betula verrucosa and RBET V1 in Spain
18 Proteomic and Immunological Characterization of Ragweed Allergens
19 Proteomic Analysis of Major and Minor Allergens From Isolated Pollen Cytoplasmic Granules
20 Cross-Reactivity Between Olive Pollen and 3 Species of Grasses in Madrid, Spain
21 Molecular Properties and Immunological Reactivity of Arabidopsis EXPB1, a Nonallergenic Homologue of Grass Group 1 Allergens
22 Protein-Protein Interactions Determine IgE Reactivity to Polygalacturonase From Cupressus sempervirens Pollen
23 Grafting of BET V 1 Epitopes onto its Homologue API G 1 Reveals Patient-Specific IgE Recognition Profiles
24 Common and Rare Variation in the T Helper 2 Gene Pathway Predicts Allergic Asthma Phenotypes
25 Role of Myeloid Derived Suppressor Cells in Asthma
26 MIR-150 Suppresses Lung Inflammation in a Mouse Model of Experimental Asthma
27 Serine Protease Inhibitor Attenuates Ova Induced Inflammation in Mouse Model of Allergic Airway Disease
28 Potential Role of Scavenger Receptors in Human Mast Cell Cytokine Response to Oxidized ldl
29 Allergic Rhinitis to Ragweed Pollen
30 Ragweed Allergy – What Role Does It Play in Bavaria?
31 Nasal Nitric Oxide and Nasal Polyposis as Determinants of Asthma Control
32 Peak Nasal Inspiratory Flow Levels in Children With Allergic Rhinitis and Their Health Related Quality of Life (HRQL)
33 Exhaled Nitric Oxide and Airway Function in Seasonal Allergic Rhinitis
34 Immunologic Evaluation of the Patients With Ranitidine Anaphylaxis
35 Body Mass Index (BMI) and Immediate (“STAT”) Dose of Epinephrine im (EPI IM) Needed to Treat Subcutaneous Allergen Immunotherapy (SCIT) Systemic Reactions (SRS)
36 Muscle Relaxant Induced Allergic Reactions
37 Features of 51 Patients With Perioperative Anaphylaxis History
38 Drug Induced Anaphylaxis in a University Hospital in Sao Paulo, Brazil
39 Analysis of Anaphylactic Reactions to Biological Agents Reported to the Italian Pharmacovigilance Database
40 Contribution of IL-33 and Nuocyte to Experimental Allergic Dermatitis
41 S100A8/A9, a Damp Molecule Activated by IL-17 and House Dust Mite is Upregulated in Atopic Dermatitis
42 Polyprenol Could Prevent Loss of Filaggrin in Epithelial Cells in Atopic Dermatitis
43 Role of Sweating on Impaired Skin Barrier Functions in Atopic Dermatitis
44 The Risk of Atopic Dermatitis in Children Exposed to Pets During Pregnancy
45 Economic Analyses of Partially Hydrolyzed Infant Formulas in Prevention of Atopic Dermatitis
46 Prevalence and Associated Risk Factors for Atopic Dermatitis Symptoms in Mexican Children
47 Involvement of Human Histamine N-Methyltransferase Gene Polymorphisms in Susceptibility to Atopic Dermatitis in Korean Children
48 Circadian Regulation of Scratching Behavior in NC/TND Mice, a Mouse Model for Human Atopic Dermatitis
49 Metallic Soap Aggravates Skin Conditions in Patients With Atopic Dermatitis and a Mouse Model for Human Atopic Dermatitis, NC/TND Mice
50 The Allergic March Resolved at Allergen Component Level
51 Prevalence of Wheezing and Risk Factors Associated to Wheezing in Infants in the First Year of Life, Cuibá, MT, Brazil
52 Risk Factors Associated to Wheezing in Mexican Children. A Multicentric Isaac-based Survey Study
55 Ocular Signs and Symptoms Elicited by a Naturalistic Allergen Challenge in an Environmental Exposure Chamber Model Versus a Direct Allergen Instillation Model
53 Association Between Eosinophil Apoptosis in Induced Sputum and Asthma Severity in Children
54 Antibiotics but not Paracetamol Reduce the Risk for Recurrent Wheezing in Infants
56 Increased Frequency of CD4+ CD25+ FOXP3- in Allergic Conjunctivitis Patients
57 Increased Frequency of CD4+ CCR4+ CCR9+ Cells in Patients With Allergic Conjunctivitis
58 Long-term IFN-γ Treatment Alters Allergic Inflammation-Associated Gene Expression in Conjunctival Fibroblasts
59 Hyperosmolar Conjunctival Provocation Test (HCPT) in the Evaluation of Ocular Symptoms
60 Tear IFN-G is Increased After Sublingual Immunotherapy in Allergic Conjunctivitis Patients and Correlates With Clinical Improvement
61 Hypoxia-Inducible Factor 1 (HIF-1) Transcription is a “Signalling Driver” for Allergic Inflammation, Host Innate Immune Defence and Leukaemia Progression
62 Keratinocytic Thymic Stromal Lymphopoietin Plays an Important Role in Epicutaneous Sensitization and the Atopic March
63 Pivotal Role of Intestinal Interleukin-17-Producing Gammadeltat Cells in the Food Allergy
64 Effect of Formoterol on Eosinophil Trans-Basement Migration Induced by Interleukin-8-Stimulated Neutrophils
65 Characteristics of Liver Injury in Drug-induced Systemic Hypersensitivity Reactions
66 Drug Reaction with Eosinophilia and Systemic Symptoms (Dress)
67 Influence of Transglutaminase and the Reducing Agent Glutathione in the Gastric Digestion and Immunogenicity of Beta-Lactoglobulin
68 Immediate and No Immediate Reactions Induced by Iodinated Contrast Medium Nonionic Among Hospitalized Patients
69 Severe Cutaneus Drug Reactions
70 Frequency of Sensitization for Food and Aero-Allergens in Patients Received in a Venezuelan Laboratory During 2010 to 2011 Period
71 Glutathione Exposed Sequential Epitopes of Ovomucoid Are Relevant for Persistent Egg-Allergic Patients
72 The Choice of Hypoallergens for Fish and Peach to Develop Food Allergy Specific Immunotherapy (TheFAST Project)
73 IFN-ã Induces Milk Allergen-Specific IL-10-Producing Regulatory B Cells in Non-IGE Mediated Milk Allergy
74 Analysis of IGE, IGE Rast Value and Prick Test in Wheat or Hen's Egg-Allergy Infants Treated with Slow Specific Oral Tolerance Induction Therapy
75 Efficacy of Slow Oral Immunotherapy for Cow's Milk Allergy
76 Factors Associated with Development of Food Allergy in Liver-Transplanted Children
77 Recurrent Wheezing in Infancy
78 Asthma Admission Rates in Germany
79 Prevalence and Classification of Asthma in Freshmen Students of a Guatemalan University and its Relationship With Aeroallegens Sensitization
80 Asthma Mortality in Brazil (1998–2006)
81 Dose Response Relationship Between Ascaris Sensitisation and Atopy and Bronchial Hyper-Responsiveness but not Allergic Diseases in Black South Africans
82 Association of Matrix Metalloproteinase-7 and -12 Genes polymorphisms With Asthma
83 Hereditary Angioedema and Normal C1-Inhibitor (HAE TYPE III)
84 Immuno-Safety of Recombinant Human C1 Inhibitor in Patients With Hereditary Angioedema
85 Clinical Efficacy of Recombinant Human C1 Inhibitor in Patients with Acute Hereditary Angioedema Attacks
86 The Efficacy and Safety of Human Plasma-derived C1-Inhibitor Concentrate Administered for the Treatment of Attacks in Pediatric Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency
87 Treatment of Idiopathic Nonhistaminergic Angiodema with Icatibant
88 Clinical Features and Diagnostic Value of Specific IGE to Component Allergen in Bee Venom Allergy in Korea
89 Is Basophil Specific Response to Hymenoptera Venom Related to T Regulatory Cells?
90 Improving the Diagnosis of Hymenoptera Venom Allergy
91 Efficacy of Venom Immunotherapy Given Every 3 or 4 Months. A Direct Prospective Comparison With the Conventional Regimen
92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy
93 Purification of the Allergenic Protein Hyaluronidase From the Venom of Social Wasp Polybia Paulista (Hymenoptera
94 High Immunogenicity of the Allergen PHL P 5 Expressed in Transgenic Mice as a Membrane-anchored Protein
95 Specific Recognition of the Major Birch Pollen Allergen BET V 1 Programs Dendritic Cells to Induce Either th2 or Tolerogenic Responses
96 Recombinant SCFV Antibodies for IGE Epitope Mapping and Detection of Parvalbumins
97 Grass Pollen Allergen-induced Surface Expression of CD203C, CD63 and CD107A on CRTH2+ Basophils
98 Specific IGE and IGG Binding to Allergoids of Phleum pratense
99 Anxiety and Depression in Patients With Variable Common Immunodeficiency in the Service of Allergy and Clinical Immunology - Centro Médico Nacional Siglo XXI
100 Computed Tomography Findings Consistent With Rhinosinusitis, Clinical Correlation and Quality of Life in Patients With Common Variable Immunodeficiency. Original Article
101 Case Report
102 Bronchiectasis
103 Modulation of Human Basophilic Responses by a Fibroleukin-Allergen Fusion Protein
104 Immunogenicity and Safety Aspects of Adeno-Associated Virus–Like Particles (AAVLPS) as Carriers for B-Cell Vaccines
105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy
106 Neisseria Meningitidis Derived Proteoliposome as an Adjuvant for Allergen Vaccines
107 Immunomodulatory Effects of Manumycin-type Antibiotics on Human Macrophages
108 The Relationship of Pets, Vitamin D and IGE Concentrations to Upper Respiratory Infections in the First Year of Life
109 Prevalence of Cockroach and Mouse Sensitization Among Children Hospitalized for Wheezing and Asthma
110 Is Pet Ownership Associated with Higher Vitamin D?
111 Taxonomic Identification of the House Dust Mites Associated to Allergic Patients in 6 Locations From Mexico
112 Comparison of the Use Ciclesonide Versus Fluticasone for the Treatment of Asthma in Children
113 Type I and III Interferon Are Attenuated in a Human In Vitro Model of Alternatively Activated Macrophages
114 A Highly Sensitive and Specific Universal Mirna Profiling Method
115 Caspase-4 Plays a Role in the Activation of the Cryopyrin/NLRP3 Inflammasome
116 Genome-Wide Association Studies of Asthma Indicate Opposite Immunopathogenesis Direction From Autoimmune Diseases
117 Allergy is an Epithelial Barrier Disease
118 EGCG Downregulates Mucin Gene Expression Through the Mapk Signaling Pathway in Asthma
119 Enhancer of Zeste Homolog 2
120 The Features of Airway Remodeling Are More Severe in Female Mice
121 Ovalbumin-induced Bronchial Asthma is Compromised in Apoptosis Signal-Regulating Kinase-Deficient Mice
122 Role of the CC− Chemokine Receptor CCR9 in the Regulation of Inflammatory Process During Allergic Airway Inflammation
123 Serum IL6 and Soluble IL6R Are Correlated With Lung Function in Non-Hispanic Whites with Asthma
124 Heterogeneity of Allergen Epitope-specific CD4+ T Cells Responses
125 The Association between Mast Cells and Remodelling of the Small Airways in Chronic Asthma
126 Creation of a Humanized Model for Respiratory Allergy Using a Human Mugwort-specificT-Cell Receptor and HLA-DR1
127 Eosinophils Enhance Airway Smooth Muscle Cell Proliferation Via the Release of Cysteinyl Leukotrines
128 Colour Change in the Human Histamine Wheal; a Sign of Desensitized Histamine Vasoconstrictory Receptors
129 Involvement of the Hypoxia-Inducible Factor-1 Transcription Complex in the Inflammatory Responses of Human Mast Cells and Basophils
130 Mutiplex Analyses of Cytokine and Chemokine Release From the Cultured Fibroblast of Nasal Polyp
131 Expression of Chemokine Receptors CCR1, CCR3, CCR4, CCR5, CCR8 and CXCR3 in Human Nasal Polyps (NP); Comparison With NP From Allergic Patients With Aspirin Intolerance
132 Characterization of 2 Epithelial Cell Air-Liquid Interface (ALI) Culture Models for Human Healthy Nasal Mucosa and Nasal Polyps
133 Corticosteroid Rreatment Reduces Tissue Eosinophilia and the Expression of Matrix Metalloproteinases (MMP-1, MMP-2, MMP-7, MMP-9) and Their Tissue Inhibitor (TIMP-1) in Nasal Polyps
134 Expression and Localization of CYSLT2 Receptor in Human Nasal Mucosa
135 Mycobacterial Infections in cChildren With Chronic Granulomatous Disease
136 Increased Pro-Inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-linked Agammaglobulinemia
137 Hypogammaglobulinemia in a Boy
138 Transmission Pattern and Carriers Identification in Male Patients with Chronic Granulomatous Disease
139 Genetic Association Study of the IgE Immunodeficiency in Mexican Population
140 Inhibition of AKT Kinase Activity Decreases Replication of Human Respiratory Syncytial Virus
141 Abnormal Immune Response Against Respiratory Pathogens in Olympic Athletes
142 The Immune Response Against Respiratory Pathogens in Patients with Chronic Rhinosinusitis/Nasal Polyps and Asthma with or without Sensitivity to Aspirin
143 Immunologic and Clinical Characteristics of Pediatric Population with Human Influenza Virus H1N1 Infection in Federal Hospital of Mexico
144 Evaluation of Various Forms of Sinusitis Using Bone Spect
145 Rhinitis
146 A 6-Week Study of the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal Aerosol in the Relief of Nasal Symptoms of Perennial Allergic Rhinitis
147 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine
148 Levels of F VCAM and ICAM in Patients With Allergic Rhino-Conjunctivitis and H1 Antihistamines
149 Once Daily Intranasal Fluticasone Furoate Decreases Daytime Sleepiness and Improves Cognitive Performance in Symptomatic Seasonal Allergic Rhinitis
150 International Survey on the Management of Allergic Rhinitis by Physicians and Patients (ISMAR). Physicians' View
151 International Survey on the Management of Allergic Rhinitis by Physicians and Patients (ISMAR)
152 Patterns of Initiation and Adherence to de novo Allergen-Specific Immunotherapy Among Adults and Children with Newly-Diagnosed Allergic Rhinitis
153 Effect of Simvastatin on Transforming Growth Factor BETA-1-Induced Myofibroblast Differentiation and Collagen Production in Nasal Polyp-Derived Fibroblasts
154 A 26-Week Study Evaluating the Safety and Efficacy of Ciclesonide Hydrofluoralkane Nasal Aerosol in Subjects With Perennial Allergic Rhinitis
155 Omalizumab Improves Asthma but not Nasal Symptoms in Japanese Patients With Severe Allergic Asthma and Rhinitis
156 Economic Evaluation of Grass Tablets for Immunotherapy (oralair) Compared to Placebo in Adults and Children in Italy
157 The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults With Allergic Rhinitis
158 Efficacy of Immnunotherapy with an Oral Bacterial Lysate and Vitamin C in the Primary Prevention of Acute Respiratory Tract Infections in Children
159 Therapeutic Effect and Safety of the Sublingual Immunotherapy With Tropical House Dust Mite Allergen Vaccines in Asthmatic Cuban Adult Patients
160 Candidate for Response Monitoring or Prognostic Biomarkers in Two-Year Sublingual Immunotherapy for Japanese Cedar Pollinosis
161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
162 Establishing the Effectiveness, Cost-Effectiveness and Safety of Oral and Sublingual Immunotherapy for Food Allergy
163 The Efficacy of Human Plasma-Derived C1-Inhibitor Concentrate Used for Prophylactic Treatment in Patients With Hereditary Angioedema Due to C1-Inhibitor Deficiency
164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
165 Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist in Patients With Hereditary Angioedema due to C1-INH Deficiency
166 Assessment of Chronic Spontaneous Urticaria by Serum-Induced TNF & ALPHA; and MMP-9 Release
167 Allergen Sensitization in Children with Allergic Rhinitis and Asthma in Guatemala
168 The Impact of Breast-Feeding Duration and Mode of Delivery on Allergic Rhinitis in Korean Children
169 The Efficacy of a Nasal Corticosteroid Ciclesonide for the Treatment of Serous Otitis Media in Atopic Children
170 Combination of a Nasal Antihistamine Olopatadine and A Leukotriene Receptor Antagonist Montelukast Sodium for the Treatment of Seasonal Allergic Patients not Currently Controlled on Monotherapy Intranasal Antihistamine or a Leukotriene Receptor Antagonist
171 Augmentation of cxcl10 Expression in Nasal Fibroblasts Derived from Patients With Recalcitrant Chronic Rhinosinusitis Associated With Bronchial Asthma
172 Correlation between CU/ZN-SOD and Macrophages or MUC5AC in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
173 Relationship Between Allergic Rhinitis and Dental-Facial Abnormalities
174 Reduction in Allergic Rhinitis Index by Decreasing Aero-Allergens and Malodor Causing Volatile Organic Compounds by Luna Air Purifiers Using Photo-Catalytic Oxidation (PCO) Technology
175 The Missing Link!! Specialist Nurse-Led Education for Parents of Children With Atopic Eczema
176 Sublingual Immunotherapy for Grass Pollen Allergy in Children
177 Effect of EPA-DHA Supplementation on Forced Expiratory Volume in One Second (FEV1) and Triglycerides in Obese Adolescents With Hypertriglyceridemia
178 A Pilot Study of Caregiver's Recall of Their Child's Skin Test Results and Environmental Remediation Education
179 Evaluation and Comparison of Lung Function by Plethysmography in Adolescents with Morbid Obesity, not Morbid Obesity and Healthy Eutrophic Children
180 Selecting Primal Therapy Appropriate for the Type of Pollinosis—Topic-J Study
181 Olfactory Disfunctions in Patients with Chronic Rhinosinusitis
182 Perceptions of Caregivers of Patients with Cow Milk Allergy Regarding the Treatment
183 Incidence of Systemic Reactions (SRS) to Prick (P) and Intradermal (ID) Tests, Response to Immediate (“STAT”) Epinephrine IM (EPI IM) Dose versus BMI, Number of Delayed SRS, and WAO Systemic Reaction Grade
184 The “Allergy Blog” and Lay Person Questions
185 Anaphylaxis after Anesthetic Reversal
186 Establishment of Reference Values for Differential Cell Counts in Nasal Lavage of Healthy Young Adults
187 Reduction in Asthma Deteriorations in Subjects with Persistent Asthma not Well Controlled on Low-, Medium-, or High-Dose Inhaled Corticosteroids
188 Efficacy Comparison of Mometasone Furoate/Formoterol Versus Fluticasone Propionate/Salmeterol Combination Therapies in Subjects With Persistent Asthma
189 Efficacy and Safety of Two Doses of Mometasone Furoate/Formoterol Combination Treatment in Subjects With Severe Asthma
190 Effect of Mometasone Furoate/Formoterol Combination Therapy on Nocturnal Awakenings in Subjects With Persistent Asthma
191 Quality of Life Improvements in Persistent Asthma Subjects Receiving Combined Mometasone Furoate and Formoterol
192 Efficacy and Safety of Combined Mometasone Furoate/Formoterol 100/10ìG Twice Daily in Subjects with Asthma Inadequately Controlled on Low-Dose Inhaled Corticosteroids
193 Prevalence of Swallowing Dysfunction in Severe Asthma
194 Influence of Montelukast on the State of Eosinophil Activation in Asthmatic Children
195 The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to Infants with Bronchial Asthma
196 Effect of the Treatment With Montelukast in Asthmatic Patient
198 AAAAI Survey on Immunotherapy Practice Patterns Concerning Dosing, Dose-Adjustment after Missed Doses and Duration of Immunotherapy
199 Development of a National Guideline on Skin Testing and Immunotherapy
200 Efficacy of Mite Sublingual Immunotherapy in 130 Children with Atopic Dermatitis
201 Clinical Efficacy and Mucosal/Systemic Antibody Response Changes After Sublingual Immunotherapy in Mite-Allergic Children
202 Treatment Satisfaction with Sublingual Immunotherapy in a Real-Life Setting
203 Long-Term Clinical Efficacy of Immunotherapy in Rhino-Conjunctivitis with Pollen Extract
204 IGE/IGG4 Ratio as a Possible Surrogate Marker of Clinical Efficacy During Allergen-Specific Immunotherapy with House Dust Mite Vaccines
205 Allergy Training and Immunotherapy in Latin America
206 Clinical Effects of Immunotherapy in Patients with Allergic Disease in the National Institute of Respiratory Diseases
207 Approach of Paediatric Allergists to Allergen Immunotherapy in Severe Persistent Allergic Rhinitis
208 Compliance and Persistence to Grass Immunotherapy Treatment is Comparable for Allergy Immunotherapy Tablets and Subcutaneous Immunotherapy
209 Fungal Sensitization and Its Relation to Asthma and Allergic Rhinitis in Children Aged 6 to 7 Years
210 Study on the Sensitization Rates to Airbone Pollen and Mold in Children
211 Influence of Degree of Specific Allergic Sensitivity on Severity of Rhinitis and Asthma in Chinese Allergic Patients
212 Allergic Sensitization to Domestic Mites in Santo Domingo, Dominican Republic
213 Prevalence Sensitizing to Most Common Allergens in Elderly in Western Mexico
214 Cross Reactivity Between Cypress Pollen and Plant Food in Queretaro, Mexico
215 Study of the Allergenic Crossreactivity and Allergenic Composition of Dermatophagoides Pteronyssinus and Blomia Tropicalis
216 Ficus Benjamina Sensitization in Adult Patients with Rhinitis
217 Identification and Statistic Analysis Related with Climatic Variability and Transportation of the Most Abundant Spores in Mexicali, Mexico
218 Thunderstorm-Related Asthma in Patients Sensitised to Olea Europaea Pollen
219 The Revised Edition of Korean Calendar for Allergenic Pollens
220 Aerobiological Study of Anemophilous Pollens in the City of Toluca, Mexico
221 Allergenic Significance of Airborne Rhizopus Stolonifer (ehrenb.) Vuill, a Common Bread Mold
222 Aerobiological and Immunological Studies on Coconut Pollen Allergy
223 Patterns of Skin Prick Test Positivity in 519 Patients with Allergic Rhinitis and Asthma in Mexico City
224 Risk Factors and Their Impact on Development and Severity of Allergic Diseases in the CIS-Region
225 Monitoring of Air-Pollutants Concentration in Children with Allergic Diseases
226 Analysis of an After-Care Questionnaire in Allergic People to Dust Mites Using Anti-Dust Mites Bed Covers
227 Changing Scenario of Airborne Allergens in Bangalore, India
228 PCR Analysis of Microorganisms in Chronic Rhinosinusitis with Nasal Polyps
229 Incidence of Allergy to Artemisia Vulgaris and Salsola Kali in Sabzevar cCty
230 The Prevalence of Allergic Rhinitis in Adolescent in La Paz, Bolivia (3600 m.s.n.m.)
231 Pattern of Positive Sensitization in Patient with Asthma and Rhinitis to 3600 MSNM (La Paz, Bolivia)
232 Epidemiology of Allergic Rhinitis Cases in the Allergy Service of a Third Level Medical Center. Six Year Experience
233 The Evaluation of Allergen Sensitivity in Allergic Rhinoconjunctivitis and Allergic Asthma Patients in Antalya, Turkey
234 Allergic Disease Severity and Relations
235 Frequency of Patients With Clinical Manifestations of Allergic Rhinitis without Evidence of Systemic Atopy and Specific ige Sensitization
236 H1 Antihistamines Influence on Pro-inflammatory Cytokines Level in Patients With Allergic Rhinitis
237 International Survey on the Management of Allergic Rhinitis by Physicians and Patients (ISMAR)
238 Effectiveness of Sinus Surgery for Lower Airway Disease
239 Berberine Inhibits Myofibroblast Differentiation in Nasal Polyp-deroved Fibroblast via P-38 Pathway
240 Mold Sensitization in Chronic Rhinosinusitis Patients
241 Nasal Cytology is Important in the Classification of Patients with Allergic and Non-Allergic Rhinitis
242 The Examination of the Association between the Chronic Rhinosinusitis and the Inflammation of the Lower Respiratory Airway by Using the Exhaled Nitric Oxide (NO) and the Respiratory Function Test
243 Peak Inspiratory Flow Rate is More Sensitive Than Acoustic Rhinometry or Rhinomanometry in Detecting Nasal Obstruction Using the Allergen Challenge Chamber
244 Nasal Poliposis and Allergic Disease. Dr. Salvador Allende Hospital
245 Use of the CT Navigation in the Rhinology and Head Surgery
246 Assessment of the Quality of Methodological Rigour and Reporting of Clinical Practice Guidelines for the Management of Allergic Rhinitis—Qugar Study
247 Health-Related Quality of Life and Prognostic Value of Acoustic Rhinometry in Patients With Perennial Allergic Rhinitis Treated with Fix Combination of Montelukast Plus Desloratadine
248 HLA-B58 Does not Increase Allopurinol Hypersensitivity among Patients with Hematologic Malignancy
249 Risk Factors Associated to Mortality in Pediatric Patients with Hemophagocytic Lymphohistiocytosis
250 The Clinical and Serological Findings in Patients with Toxocariasis in Korea
251 Interferon-Gamma Release Assay—Useful Tool for the Diagnosis of Pleural Tuberculosis
252 The Parasite Echinococcus Granulosus Promotes Allergic Response in Human
253 Use of Transfer Factor in Patients with Persistent Genital Human Papillomavirus Infection
254 Experimental Heterophyiasis
255 Chronic Obstructive Pulmonary Disease and Lung Cancer Share Inflammation Pathways
256 Risk Factors of Recurrent Upper Respiratory Infections in Children under 5 Years. Habana Vieja
257 Long Term Asbestos Exposure as a Cause of Eozinophilic Pleural Effusions
258 A Novel Therapeutical Option in Resistant Ganglionar and Cutaneous Tuberculosis
259 Penicillin Allergy Evaluation
260 Association Between Genetic Polymorphisms of ABCC2 Transporter and the Susceptibility to Maculopapular Eruption Induced by Antituberculosis Drugs
261 The Real Use of Beta-Lactams after "Penicillin Allergic" Label Removal
262 Hypersensitivity to Beta-Lactam Antibiotics Evaluation Using the European Network Drug Allergy (ENDA) Algorithm
263 Clinical Features of Drug Rash with Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculous Medications
264 Basophil-Mediated Anaphylaxis Triggered by Drug-Activated Complement Alternative Pathway Without Mastocyte's nor Immunoglobulins Involvement
265 Wait at Least 60 Minutes After Eating
266 First Report of Anaphylactic Shock Caused by the Ingestion of Mite-Infested Flour in Panama
267 Recurrent Aanaphylaxis in Cow Milk Allergy
268 Epidemiology of Anaphylaxis in Adults Treated in the Emergency Department, of the University Hospital of Monterrey n.l Mexico, During 2005–2010
269 Refractory Chronic Urticaria Treated with Omalizumab
270 Clinical Experience in Allergic Asthma Patients
271 Evaluation of Adverse Events Associated to Administration of Omalizumab
272 Gender and Different Prevalence in Asthma Treatment With Anti-IGE (Omalizumab)
273 Fetal Loss in Severe Asthma and Posterior Healthy Pregnancy and Birth with the Use of Omalizumab—Case Report
274 Vasculitic Urticaria Treated with Omalizumab. Case Report
275 Efficacy of Omalizumab in the Treatment of Urticaria-Vasculitis Associated to Churg-Strauss Syndrome
276 A 4-Year Follow-up in Children With Moderate/Severe Asthma after Withdrawal 1 Year Omalizumab Treatment
277 Serum Soluble Trail Levels in Patients With Severe Persistent Allergic Asthma
278 Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients With Severe Persistent Allergic Asthma
279 Near-Fatal Asthma Treated with Omalizumab
280 Use of Omalizumab in Chronic Moderate to Severe Persistent Asthma-an Indian Experience
281 Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic
282 Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation
283 Relationship between Aeroallergen Sensitization and Asthma Severity in Patients with Aspirin-Exacerbated Respiratory Disease
284 Persistence of Nasal and Bronchial Symptoms in Patients with Samter's Syndrome with Treatment Medical and Surgical in a 2 Year Period
285 Clinics and Laboratory Characteristics of Asthmatic Patients with Aspirin Exacerbated Respiratory Disease (AERD)
286 Association Analysis of Member RAS Oncogene Family Gene Polymorphisms with Aspirin Intolerance in Asthmatic Patients
287 Nasal Nitric Oxide Levels after Lysine Aspirin Nasal Challenge in Subjects with Aspirin Induced Asthma
288 IL1B but not IL8 Polymorphisms Are Increased in Aspirin Exacerbated Respiratory Disease Patients Versus Aspirin Tolerant Asthmatics
289 Fatty Acid Binding Protein 1 is Related with Development of Aspirin-Exacerbated Respiratory Disease
290 The Correlation of Cholesterol Lowering Statin Drugs and Worsening Asthma Control in Mild Persistent Asthmatics
291 Studies on the Relationship between Airway Inflammatory Responses in Patients With Asthma or Not-yet Onset Asthma and Air Pollution
292 The Relationship Between Maternal Atopy and Childhood Asthma
293 Sensitization of Severe Allergic Asthma Patients
294 Reference Values and Influencing Factors of Exhaled Nitric Oxide in Healthy Korean Adults
295 Association of Feno with IgE Levels in Patients with Allergic Asthma
296 The Relationship of Fractional Exhaled Nitric Oxide (FeNO) and Acute Exacerbation of Childhood Asthma
297 Relationship Between Exhaled Nitric Oxide and Levels of Asthma Control in Asthma Patients Treated with Inhaled Corticosteroid
298 Relationship between Aeroallergen Sensitization and Asthma Severity in Mexican Children
299 Association of Asthma and IGE Levels
300 The Method of Antigen Specific Damage of Leucocytes by Food Additives in Patients with Bronchial Asthma
301 Effect of Ascorbic Acid on Aiway Hyperresponsiveness in Bronchial Asthma
302 Screening for Allergic Bronchopulmonary Aspergillosis in Patients with Aspergillus + Asthma From 2000 to 2010
303 Sleep-disordered Breathing in Obese and Eutrophic Adolescents, Asthmatics and not Asthmatics, in the Hospital Infantil of Mexico Federico Gómez
304 Dyspnea in Chronic Fatigue Syndrome (CFS)
305 Incidence of Allergy in Patients With Benign Lesions of the Vocal Cords
306 Eechocardiographic Findings in Obese Adolescents with and without Asthma
307 Asthma Prevalence and Body Mass Index in Children
308 Evaluation and Comparison of Lung Volumes and Capacities in a Group of Morbid Obese, Obese and Eutrophic Adolescents
309 Difficult-to-treat Asthma with Idiopathic Chronic Eosinophilic Pneumonia
310 Diagnosis and Management of Post-radiation Pneumonitis in Patients with Asthma
311 Pathogenesis of Radiation-induced Pneumonitis in Patients with Chronic Obstructive Pulmonary Disease
312 Medication Responses in Chronic Fatigue Syndrome (CFS) and Non-CFS Subjects
313 Psychogenic Intractable Sneezing. Case Report
314 GERD Screening by the Use of F-Scale and Allergy Screening for Diagnosis and Treatment of Chronic Cough
315 Diagnosis of Gastroesophageal Reflux Disease in Patients with Chronic Cough
316 Botox Injections in Larynx as a Treatment for Vocal Cord Dysfunction
317 Myasthenia Gravis and Asthma, Relationship between Two Different Disorders of the Immune System
318 Immunological Characteristics of Patients with Bronchial Asthma and Obesity
319 Bronchial Hyperresponsiveness in Obese Adolescents
320 Development of a Questionnaire for the Assessment of Bronchial Hyperresponsiveness in Korea
321 Clinical Analysis of Salbutamol Responsiveness after Acetylcholine-induced Bronchoconstriction in Childhood Asthma
322 Preoperative Cardiopulmonary Exercise Testing (CPET) in Severe Asthma Patients
323 Annual Change of Peak Expiratory Flow Rate in Asthma and COPD
324 Evaluation of Chest Computed Tomography in Patients with Asthma
325 Exercise-induced Airway Obstruction and Vitamin D Deficiency
326 Lung Age/Chronological Age Index as Indicator of Clinical Improvement or Severity in Asthma Patients
327 Transition from Cough Variant Asthma to Asthma With Reduced FEV1
328 Epidemiology of Asthma Cases in the Allergy Service of a Third Level Medical Center. Six Year Expirience
329 Latin America Asthma Insight and Management (LA AIM)
330 Understanding of Asthma Terminology by Patients Interviewed in the Latin America Asthma Insight and Management (LA AIM) Survey
331 Asthma Management in Latin America
332 Project for Prevention & Control of Asthma and Allergic Diseases in Korea
333 Asthma in the CIS-region
334 Asthma in the Elderly
335 Control of Asthma and Its Relationship to Quality of Life in Adolescents
336 The Leukotriene C4 Synthase (A-444C) Promoter Polymorphism in Venezuelan Individuals with Asthma
337 Allergic Disorders Prevented by Helicobacter Pylori Colonization
338 Early Clinical Differential Diagnosis between Infant Atopic Dermatitis and Seborrheic Eczema
339 Sensitization to Contactants in Patients with Atopic Dermatitis
340 Sensitization to Aeroallergens and Risk of Respiratory Allergy in Atopic Dermatitis Children
341 Quality of Life in Pediatric Patients with Atopic Dermatitis
342 Epidemiology of Atopic Dermatitis in the Allergy Service of a Third Level Medical Center
343 Gene-environment Interactions on the Development of Atopic Dermatitis in Preschool Children
344 FcRγ-mediated Immune Responses Modulate the Exacerbation of Clinical Symptoms in Atopic Dermatitis of NC/TND Mice
345 Autoimmune Diseases and Risk of Stroke
346 Clinical Effects of Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, on Patients with Autoimmune and Allergic Diseases
347 Association between Autoimmune Reactions, Herpes Infection and Severity of Atopic Dermatitis in Children
348 Immunomodulatory Effects of Extracorporeal Photochemotherapy in Systemic Sclerosis
349 Detection of Anti-nucclear Antibodies (ana) Used for Diagnostic Approach of Systemic Autoimmune Diseases. Correlation with Double Stranded DNA (DSDNA) and Extractable Nuclear Antigen (ENA) Antibodies
350 The Vasculitis Induced by the Cerebrovascular Coil
351 Prevalence of Thyroid Peroxidase Autoantibodies (ANTI-TPO) in Women with Autoimmune Connective Tissue Diseases (ACTD)
352 Anticardiolipin Antibodies in Patients with Acute Myeloid Leukemia
353 Alopecia as a Symptom of Neonatal Lupus
354 Autoimmune Hepatitis Misdiagnosed as Hepatitis C Responding to Interferon/Ribavirine Therapy
355 Ocular Muscles Myopathy Associated with Autoimmune Thyroiditis. Case Reports
356 Pulmonary Arterial Hypertension Associated to Antiphospholipid Syndrome in an Infant
357 Tear IL-4 is Decreased in Allergic Conjunctivitis Patients with Negative Skin Test After Dialyzable Leukocyte Extracts Treatment
358 Histochemical Study of Allergic Inflammation in Conjunctiva From Ovalbumin Sensitized Rabbits after Ocular or Nasal Challenge
359 Prevalence of Allergic Conjunctivitis in Childhood
360 Effects of Omalizumab in Children with Atopic Keratocojunctivitis
361 Giant Papillary Conjuntivitis without Associated Triggers. Report of Two Cases
362 Contact Allergy Due to Ophthalmic Drugs in Uruguay
363 Increased Frequency of γδ T Cells in Patients with Allergic Conjunctivitis
364 Zero Itch in Eyes Treated With Olopatadine Hydrochloride Ophthalmic Solution, 0.2% in Bilateral Conjunctival Allergen Challenge Studies
365 Patch Testing Results in Contact Dermatitis from the Allergist's Perspective
366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay
367 Evaluation of Allergen Sensitivity in Patients with Contact Dermatitis in Antalya
368 Better Protection from Eczema Among Turkish Migrants' Children Carries Over from Preschool Age to Adolescence
369 Comparison of Skin and Conjunctival Reactivity to Aeroallergens
370 Correlation Between Skin Prick Test and Mast Results in Patients with Chronic Rhinitis
371 Cutaneous Response to Patch Tests with Dermatophagoides Farinae and Dermatophagoides Pteronyssinus in Patients with Chronic Rhinitis
372 Skin Prick Test Reactivity Compared to Serum Specific IGE by ISAC in Patients With Rhinitis
373 Alteration of Smell in Patients with Persistent Allergic Rhinitis
374 Effectiveness of an Educational Intensive Course on A/I Clinical and Diagnostic Procedures
375 Non-steroidal Anti-inflammatory Drugs Hypersensitivity
376 Epidemiology of Immediate Type Adverse Drug Reactions and Rashes Elicited by Nsaid
377 Test in Vitro to Investigate the Cytotoxicity and Cellular Nonspecific Stimulation of Basophils with Indomethacin
378 Aspirin Desensitization Treatment
379 Adverse Drug Reactions to Anti-asthmatics in Patients with Bronchial Asthma
380 Presentation of Three Cases of Allergic Reactions to Triptorelin
381 Adverse Drug Reactions in Hospitalized Patients
382 An Unusual Reaction to Intravenous Iron Sucrose
383 Urticaria and Arthralgias in a Nine-Year-Old with Recurrent Urinary Tract Infections
384 Jessner-kanoff Lymphocytic Infiltrate as a Side Effect of Immunotherapy
385 Improvement of Oral Lichenoid Reaction Symptoms after Removal of Amalgam Restorations
386 Hypersensitivity Reactions to Interferon Based Treatment for Hepatitis C
387 Hypersensitivity Syndrome Associated with Phenytoin Sodium
388 Drug Hypersensitivity Reactions in Hospitalized Patients
389 Allergic Reactions to Local Anesthetics
390 Protamine Allergy
391 Description of Drug Allergy Study Conducted in a Teaching Hospital between October 2007 and March 2011
392 Lung Toxicity Induced by Novel Antineoplastic Therapies in Cancer Patients
393 Redness of Skin
394 Desensitization Protocol to Methotrexate
395 Clinical Features of Dress Syndrome in 42 Patients
396 Risk Factors Associated to Mortality in Mmexican Children with Stevens-Johnson Sndrome/Toxic Epidermal Necrolysis
397 Standardization and Characterization of Dust Mite Extracts Manufactured in the USA
398 Detection of DER P 2 in the House Dust and Correlation with Mite Number in an Environmental Survey
399 Daily Vacuum Cleaning Significantly Reduces House Dust Mite Allergen, Endotoxin and β-glucan Content of Mattresses
400 Differences in Indoor Allergen Quantification in Hispanic/Latino Children Living in Miami to Those Living in Latin America
401 House Dust Mite Fauna and Its Relationship to Allergen Skin Tests in Six Mexican States
402 Oral Mite Anaphylaxis is Caused by Mite-contaminated Okonomiyaki Mix in Japan
403 International Survey on Evaluation and Management of Eosinophilic Esophagitis
404 Allergen Specific Immunotherapy as a Treatment for Eosinophilic Esophagitis
405 Treatment of Nasal Allergies
406 Comorbid Allergy-related Respiratory Conditions Among Children and Adults Diagnosed with Allergic Rhinitis
407 Survey of Rhinitis Phenotypes
408 Prevalence and Risk Factors Associated to Symptoms of Rhinoconjunctivitis in Mexican School Children. A Multicenter Study
409 Oral Allergy Syndrome and United Airways Disease
410 Epidemiological and Clinical Characteristics of Allergic Conjunctivitis Patients in a Reference Center of Mexico City
411 The Classification of Allergic Rhinitis and Its Cytological Correlate
412 Incidence of Allergic Diseases on Children under 5 Years in Juarez Hospital Mexico
413 Effect of Hydrolysis and Polymerization on Bovine Beta-lactoglobulin Immunoreactivity
414 Immunoreactivity of Polymerized and Digested Beta-lactoglobulin to IgE from Milk Allergic Patients
415 Identification of Novel Allergens in the Fish Parasite Anisakis Simplex
416 Milk Components as a Tool in Predicting Tolerance in Cow's Milk Allergy
417 Uncommon Occupational Allergy to Rice
418 Frequency of Food Hypersensitivity Mediated by IGG in Patients Received in a Venezuelan Laboratory During 2011
419 IGE-mediated Responses Towards Fish Parasite Anisakis, Crab and House Dust Mite in Norwegian Shrimp Allergic Individuals
420 Lentil Allergy
421 Cow's Milk Allergy and Persistent Changes in a Multiple Food Allergy, A Case Report
422 A Rare Case of Food-induced Anaphylaxis to Pink Peppercorns
423 Multiple Manifestations of Food Allergy in a Patient with a Change of Eating Habits
424 Wheat-dependent Exercise-induced Anaphylaxis Occurred in OAS Patient after Using Soap Containing Hydrolyzed Wheat Proteins
425 Possible Prenatal Sensitization
426 The Evaluation of Allergen Sensitivity in Food Allergy Patients in Antalya, Turkey
427 Clinical Correlation of Prick and Prick-to-Prick Skin Tests to Food in a Group of Children with Allergy Symptoms
428 Comparison Skin Prick Test Using Commercial and Native Extracts of Allergens in Diagnosis of Food Allergy
429 Natural History of Food Allergy in Childhood -3 Years' Follow up of Pediatric Food Allergy Patients
430 Comparative Analysis of Patients with Birch Pollinosis and Patients with Associated Plant Food Allergy
431 Frequency and Characterization of Oral Allergy Syndrome in Mexican Adults with Nasal Pollinosis
432 Patterns of Sensitization to Common Food and inhalant Allergens and Allergic Symptoms in Preschool Children
433 Sensitization to Food Allergens in Patients of the Allergy Service of the University Hospital of Monterrey, Mexico
434 Frequency of Food-sensitization by Prick-to-Prick Test and Atopy Patch Test in Allergic Children
435 Increasing Incidence of Food Allergy in Zimbabwe
436 Ten Years Follow up of Japanese Survey on Immediate Type Food Allergy
437 Association between Cows Milk Allergy and Gastroesophageal Reflux Disease on Mexican People
438 An Investigation of Food Choice Behaviour of Food Allergic and Non-food Allergic Children
439 Probiotic Effect of the Regulation of Innate Immune Response, dc and Adaptive Cellular Immune Response and the Balance TH1, TH2, TREG Through Sensors TLR-2 AND TLR-4, on the Intestinal Mucosa in BALB/C Health Status and Balb/C Status of Exposure to LPS
440 Gluten Induced Systemic Disease (GISD) with Distinct Clinical Phenotype Different from Celiac Disease
441 Patterns of Food Allergens in Kenyan Children
442 Coincidence of Celiac Disease and Gluten Allergy
443 Immunoreactivity of ß-Lactoglobulin and Identification of the Peptides Generated after Simulated Orogastrointestinal Digestion
444 Associations between Self-reported Adherence to Asthma Anti-inflammatory Therapy and Risk Factors for Non-adherence (NA) in Pediatric Patients
445 Inability of Medical Students to Use of Three Types of Inhaler
446 Impact of Providing Physical Education Teachers with Information about Asthma When Training Children and Adolescents with This Disorder
447 Asthma Knowledge among Parents and/or Caregivers of Asthmatic Children Attending a Practical Allergy Course
448 Ezhengtricity 2010
449 Usefulness of Asthma Control Test Questionnaire, FEV1 and Exhaled Nitric Oxide Level (FENO) for the Clinical Assessment of Elderly Asthma
450 Systematic Review of the Recommendations on the Prevention of Allergic Manifestations in Children
451 The Relationship Between Emotional Cognition and the Symptom Gap in Patients with Bronchial Asthma
452 Asthma Control and Quality of Care of Adult Asthma Patients in Primary Health Care Facilities in Saint-Petersburg, Russia
453 A 26-Year Review of Long-term Safety of a Human Pasteurized C1 Inhibitor Concentrate
454 Efficacy of Icatibant Versus Fresh Frozen Plasma for Attacks of Hereditary Angioedema
455 Characterization of the Factors Triggering an Edematous Attack in Hereditary Angioedema
456 Hereditary Angioedema
457 Clinical Features and Outcome of 82 Patients with Hereditary Angioedema
458 Differences of Complement Activation Profile between Type I and Type II of Hereditary Angioedema Due to C1-inhibitor Deficiency
459 Peculiarities of HIV-specific Immune Response in Discordant Couples
460 Detection of Dengue Virus in HIV-1-infected Patients during the Epidemic in 2009 in Colima, Mexico
461 HPV, HSV2, HIV AND Chlamydia Trachomatis Infections as a Potential Accompanying Factor for Immunodeficiency and Development of Allergic Processes. Final Results
462 When Honeybees Attack
463 Efficacy of Immunotherapy With Allergenic Extract of Aedes Aegypti in the Treatment of Large Local Reaction to Mosquito Bites in Children
464 Specific Venom Ige Decrease during 5 Years of Venom Immunotherapy (VIT)
465 Skeeter Syndrome, a Case Report and Literature Review
466 Bee venom Immunotherapy with Standardized Extract, Two Case Comunication and Clinical Progress
467 Clinical Case. Bee Venom Anaphylaxis
468 Urticarial Vasculitis After Bee-sting Therapy
469 Levels of IL-4, INF-Γ Total IGE and IGG4 in Serum of Allergic Children within Areas of Risk of Lead Exposure in Torreon Coahuila, Mexico
470 Relationship of Blood Lead Levels with Total Ige in Teenagers with Environmental Exposure in Torreon Coahuila, Mexico
471 IgE from Birch Pollen Allergic Patients Cross-reacts with Two Distinct Bet V 1 Related Proteins in Mung Beans
472 Heterogeneity of the Ige Response to Allergenic Determinants of Cefotiam in Serum Samples From Patients with Cefotiam-induced Occupational Allergy
473 Evaluating Total Serum IgE Levels in Patients with Chronic Hepatitis B and C
474 Relationship Between Total Serum IgE, Atopy, and Obesity in Children With or Without Family History of Atopic Disease
475 The Candidate Peptides in IgE for Allergy Vaccine Design
476 Severe Autoimmunity with Polyarticular Joint Disease Requiring Anti-TNF Therapy and T+B-NK+ Immunodeficiency in a Family with Small Stature and Intermediate Radiation Sensitivity
477 Autoimmunity in Patients with Allergy and Immunodeficiency
478 HPV, HSV2, HIV AND Chlamydia Trachomatis Infections as a Potential Accompanying Factor for Immunodeficiency and Development of Allergic Processes. Final Results
479 A 3 Year-old Child with Specific Antibody Deficiency and Allergic Rhinitis. A Case Report
480 Silvery-gray Hair Patient with neurologic deterioration
481 Differences in Humoral and Cellular Immunity in Young and Old Individuals
482 Analysis of the Immune Status in the Acute Phase of Viral Respiratory Infections in Children
483 Immunomodulatory Effects of Human Bone Marrow-derived Mesenchymal Stem Cells
484 Allergen Standardisation in Allergens and Allergoids—Challenges and Considerations
485 Therapeutic Effect and Safety of Tropical Mite Allergen Vaccines by Subcutaneous Route in Allergic Asthmatics Patients
486 Therapeutic Effect and Security in Asthmatics Adult Patients Treated with Dermatophagoides Pteronyssinus Allergen Sublingual Immunotherapy
487 Safety of Sublingual Immunotherapy with Standardized Vaccines of Domestic Mites
488 The Effect of Specific Immunotherapy on the Clinical Response in Patients with Grass-pollen Induced Rhinoconjunctivitis
489 Does Sublingual Immunotherapy Work with an Immune Deviation Mechanism?
490 Immunotherapy (IT) Training in Canada
491 Immunotherapy (IT) Training in Canada
492 Nationwide Survey of Immediate Type Food Allergy in Japan
493 The Prevalence of Food Allergy in Children under 2 Years in Three Cities in China
494 Skin Sensitization to Carmine Before Onset of Systemic Allergy to Ingested Carmine
495 Milk, the Most Commonly Undeclared Food Allergen Causing Unexpected Allergic Reactions in Sweden between 2004 and 2011
496 Cross Sectional Study of 1,822 Pediatric Food Allergy Patients
497 Surface Plasmon Resonance Imaging
498 Mastocytosis and IgE-dependent Sensitization
499 Mastocytosis
500 Human Mononuclear Phagocytes Are Regulated by a Cross-talk with Epithelial Cells
501 Activation of PAR-2 Induces Myofibroblast Transformation via a TGF-β and GSK-3β/β-catenin Dependent Pathway in Tissue Remodeling in the Asthmatic Lung
502 Plasminogen Activator Inhibitor-1, Fibrinogen and Lung Function in Adolescents with Asthma and Obesity
503 Peculiarities of Immune Response in Young Children with Recurrent Wheezing
504 Participation of Invariant NKT Cells (Vα24Jα18) during Asthma Exacerbation in Children
505 Cytokine Profile Characterization in Patients Infected with AH1N1 Influenza Virus
506 Basal T Cell Subpopulations of Normal Humans Vary by Stress Hormone Receptor Polymorphisms
507 The Protective Effects of Exogenous IGFBP-3 on Allergic Airway Inflammation through Blockade of vegf Production
508 Antioxidants Attenuate Airway Remodeling by Regulating NF-ÊB, NRF2, and HIF in a Murine Model of Chronic Asthma
509 CCL3L1 Protein Did Not Affect IL-6 Expression, but Significantly Up-regulated IL-10 Expression in the Allergic Response
510 Caspase-9 is Involved in CD30 Activation Induced Eosinophil Apoptosis
511 Role of NLR (Nucleotide Oligomerization Domain (NOD)—like Receptor) on Allergic Inflammation in a Mouse Model of Allergic Rhinitis
512 MUTANT IL-3
513 IL-17 Role in the Regulatory Function of B Cells
514 Role of TH-17 Cytokines in Steroid Insensitivity in Peripheral Blood Mononuclear Cells. Relationship to GR-alpha and GR-beta Expression
515 Prevalence of Latex Sensitization Between Medicine and Dentistry Students from Nuevo Leon University
516 Profile of Latex Sensitization in Children with Myelomeningocele of São Paulo, Brazil
517 Specific IgE to Recombinant Allergens of Latex and Foods in Patients With Spina Bifida
518 Association between Clinical History and Specific IgE Recombinants Latex Allergens
519 Occupational Flaxseed Allergy (Conjunctivitis)
520 Involvement of Il-10 Gene Promoter Polymorphisms in the Susceptibility for Childhood Asthma
521 Serum NT-3 and NT-4 Levels are Associated with Clinical Severity in Asthmatic Children
522 Association between Eosinophilic Airway Inflammation and Persistent Airflow Limitation in Asthmatic Children
523 Not All Who Wheeze Have Asthma—Tracheal Diverticulum with Stenosis of Trachea in 9 Years Old Boy
524 Reccurent Wheezing in Childhood—Is It Always Asthma?
525 Bronchial Hyperresponsiveness in Children with Suggestive Asthma Symptoms
526 Relationship between Fractional Exhaled Nitric Oxide (Feno) and Forced Expiratory Volume in One Second (Fev1) and Forced Vital Capacity (Fvc)i Children with Asthma
527 Evaluation of the September Epidemic of Asthma Exacerbation in Children in Our Practice
528 Elevated Asthma Prevalence in Mexican-American Children in El Paso, Texas
529 Prevalence of Bronchitis and Revealing of the Risk Factors in the Children's Population
530 Atopic Phenotype in Children under 6 Years with Persistent Wheezing in El Salvador
531 Comparison of Exhaled Nitric Oxide and Spirometry in Hispanic/Latino Children Living in Miami to Those Living in Latin America
532 Maximum Expiratory Flow in Health Children from the Metropolitan Area of Monterrey Mexico
533 Viral Respiratory Infections and the Development of Atopy and Asthma
534 Clinical Characteristics of Eosinophilic Asthma Compared to Noneosinophilic Asthma in Children
535 Correlation between Quality of Life and Treatment Adherence in Childhood Asthma
536 Effect of Diet Supplementation with Epa-Dhe on Pulmonary Function Tests and Metacholine Bronchial Challenge Test in Obese Mexican Children
537 Use of Complementary and Alternative Medicines by Children Suffering from Asthma at Mangalore, India
538 Long-term Follow Up Outcomes of Early Intervention with Anti-Inflammatory Therapy in Patients with Asthma Under 2 Year-old
539 Asthma Treatment May Be Useful to Treat Recurrent Wheezing in Infancy
540 Trans oro Pharyngeal Spacer for Inhalers
541 Intravenous Immunoglobulin in Leukocyte Adhesion Deficiency
542 Descriptive Analysis of the Immunological Behavior of Patients with Ataxia Telangiectasia Attended in the National Institute of Pediatrics in the Past 30 Years
543 Alteration of Humoral and Cellular Immunity in Patients with Ataxia-Telangiectasia at Reference Center in Sao Paulo, Brazil
544 Clinical Features of Patients with Ataxia-Telangiectasia at Reference Center in Sao Paulo, Brazil
545 Global Prevalence and Types of Autoimmune Diseases Found in Children with Primary Immunodeficiencies; A Single-Center Experience
546 Malignancies Associated to Primary Immunodeficiencies. A 40 Year Review
547 An Earlier, More Severe Presentation of G6pc3 Deficiency in a Male Infant From Mexico
548 Immunoglobulin a Deficiency, HPV and Oral Cancer
549 Management of Twenty-Five Pediatric Patients with Hereditary Angioedema (Hae) Undergoing Home Treatment—A Clinical Surveillance Program
550 The Impact of Nasal Allergies
551 The Impact of Nasal Polyposis on Quality of Life Using the Eq-5d Health Profile
552 Predictors Affecting the Quality of Life of Patients with Bronchial Asthma
553 Correlation between Severity of Allergic Rhinitis and Impairment of Quality of Life in Allergic Adolescents
554 Chronic Urticaria Quality of Life Questionnaire (Cu-Q2 Ol) and Urticaria Activity Score (Uas)
555 Frequency, Characteristics and Outcome of Immediate Hypersensitivity Reactions Due to Iodinated Contrast Media
556 Frequency of Positive Skin Test for Iodinated Contrast in Outpatient Clinic of Allergy in Rio De Janeiro, Brazil
557 Test and Manage Protocol for 841 Patients Requiring Iodinated Contrast Media (Icm) in Pediatrics
558 Severe Asthma
559 Risk Factors for Bronchial Asthma in Central Havana in the Period 1995–2010
560 Dolichyl Phosphate Dependent Mechanism of Exacerbations in Asthma
561 Distribution of Asthma Mortality in Various Districts of Salvador, Brazil
562 Geographical Distribution of Deaths from Asthma in Salvador, Brazil (2000–2009)
563 Measurement of Long-acting Natriuretic Peptide (Lanp) in Exacerbation of Asthma
564 Is It Really Difficult-to-treat Asthma? Don't Forget Other Causes of Wheeze
565 Sensitization Profile in Severe Asthma
566 Utility of Component-Based Allergen Chip (Immunocap Isac) in Diagnosis of Allergic Rhinitis
567 Prevalence of Skin Reactivity to Blomia Tropicalis Antigen in Patients with Respiratory Allergy at Hospital Universitario De Puebla
568 Prevalence of Sensitization to Parietaria, Pinus, Cupressus and Morus Pollens in Patients from Craic
569 Prevalence of Skin Reactivity to Antigen Mus Musculus in Patients with Respiratory Allergy
570 Atopy Patch Test to Aeroallergens Extracts is Useful In Allergic Diseases Diagnosis When Skin Prick Test is Negative
571 Clinical and Laboratory Studies of the Fate of Intranasal Allergen
572 Effect of Enzymatically Modified Isoquercitrin, a Flavonoid, on Symptoms of Japanese Cedar Pollinosis
573 Prevalence of Allergen Sensitization in Children with Atopy Suspicion between Six Months and Five Years of Age
574 Prevalence Allergic Diseases and Allergic Sensitization among Urban Office Workers as Compared with a Forest Service Workers
575 Photoaging Attenuates Skin Test Response to Histamine More Than Natural Aging
576 Hla and Chronic Urticaria with Positive Autologous Serum Skin Test among Brazilians
577 CD63 Expression, IL3 Receptor, IGG Autoantibody and Autologous Serum Skin Test Accuracy in Patients with Chronic Urticaria in Brazil
578 Comparison of the Modified Autologous Serum Skin Test and the Cd63 Basophil Activation Test in Chronic Urticaria
579 The Frequency of Positivity in Autologous Serum Skin Test in Patients with Chronic Idiopatic Urticaria
580 Eleven Cases of Angioedema with Eosinophilia Treated in a Single Hospital in Japan
581 Chronic Urticaria and Infections
582 Chronic Urticaria Associated with Thyroid Disease
583 Epidemiology of Urticaria Cases in the Allergy Service from a Third Level Medical Center. Six Year Experience
584 Frequency of Autoreactivity Demonstrated by Autologous Serum Skin Test in Patients with Chronic Urticaria in the Valley of Mexico During a Period of 8 Years
585 Chronic Idiopathic Urticaria and Neglected Toxocara Infection
586 Mucocutaneous Disease as a Presentation of Hereditary Angioedema. Report of 2 Cases
587 Plasmapheresis in a Patient with “Refractory” Urticarial Vasculitis
588 Delayed Diagnosis of Hereditary Angioedema. A Case Report
589 Urticaria Pigmentosa. Case Report
590 A Case of Chronic Urticaria Complicated by Raoultella Ornithinolytica Urinary Tract Infection, Bronchospasm and Angioedema
591 A Case of Idiopathic Recurrent Isolated Orbital Angioedema with Exophthalmos
592 A Case of Multiple Simultaneous Urticarial Syndromes Refractory to Treatment
593 Chronic Urticaria as First Sign of Sarcoidosis
594 Life-Threatening Angioedema without Urticaria (Ae-U)
595 Urticarial Rash Associated with Chest Pain
596 Application of Intravenous Immunoglobulin for Treatment of Chronic Autoimmune Urticaria
597 Long Term Follow-up of Patients with Common Variable Immunodeficiency (Cvid) in Rio De Janeiro, Brazil
598 Quality of Life in Patients with Common Variable Immunodeficiency in the Department of Allergy and Clinical Immunology—Centro Medico Nacional Siglo XXI
599 Prevalence of Common Variable Immunodeficiency in Adult Patients Specialty Hospital—Centro Medico Nacional Siglo XXI - Mss—Mexico City
600 Infections in 14 Patients with Common Variable Immunodeficiency, Retrospective Study
601 Autoimmune Thrombocytopenic Purpura Associated with Common Variable Immunodeficiency
602 Cvid
603 Infections in Patients Diagnosed with Common Variable Immunodeficiency
604 Phenotypic and Functional Analysis of B Cells in Patients with Common Variable Immunodeficiency
605 X-linked Agammaglobulinemia
606 Case Report
607 X- Linked Agammaglobulinemia and Moebius Syndrome, First Case Reported